Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Foods (Basel, Switzerland)|October 31, 2020
Cricket-Enriched Oat Biscuit: Technological Analysis and Sensory EvaluationBarbara Biró, Mária Anna Sipos, Anikó Kovács, et al.Bioorganic & Medicinal Chemistry Letters|October 8, 2013
Synthesis and biological evaluation of novel pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell linesLászló Kékesi, Anna Sipos, Gábor Németh, et al.European Journal of Medicinal Chemistry|January 3, 2016
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cellsRita Garamvölgyi, Judit Dobos, Anna Sipos, et al.Acta Pharmaceutica Hungarica|December 5, 2014
[Pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines, and their preparation via regioselective condensation reaction]László Kékesi, Anna Sipos, Gábor Németh, et al.Oncotarget|September 17, 2019
Targeted drug combination therapy design based on driver genesLilian Zsákai, Anna Sipos, Judit Dobos, et al.Bioorganic & Medicinal Chemistry Letters|January 14, 2018
Novel compounds with potent CDK9 inhibitory activity for the treatment of myelomaZsófia Czudor, Mária Balogh, Péter Bánhegyi, et al.European Journal of Medicinal Chemistry|October 16, 2019
Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinasesFerenc Baska, Anna Sipos, Zoltán Őrfi, et al.Tuberculosis (Edinburgh, Scotland)|March 25, 2015
Lead selection and characterization of antitubercular compounds using the Nested Chemical LibraryAnna Sipos, János Pató, Rita Székely, et al.Journal of Medicinal Chemistry|April 19, 2014
Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitorsGábor Németh, Zoltán Greff, Anna Sipos, et al.Pageof 1